Accès à distance ? S'identifier sur le proxy UCLouvain
Evaluation of the performances of the new Synchron (R) C-RP reagent in the determination of the atherosclerotic risk in apparently healthy patients.
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection |
|---|---|
| Publication date | 2003 |
| Language | Anglais |
| Conference | "55th Annual Meeting of the American-Association-for-Clinical-Chemiatry", PHILADELPHIA (Pennsylvania) (Jul 20-24, 2003) |
| Journal information | "Clinical Chemistry (Washington, DC) : international journal of molecular diagnostics and laboratory medicine" - Vol. 49, no. 6, p. A113-A114 (2003) |
| Peer reviewed | yes |
| issn | 0009-9147 |
| e-issn | 1530-8561 |
| Publisher | Amer Assoc Clinical Chemistry (Washington) |
| Affiliation | UCL - MD/BICL - Département de biochimie et de biologie cellulaire |
| Links |
| Bibliographic reference | Wawrzyniak, J ; De Nayer, Philippe ; Philippe, Marianne. Evaluation of the performances of the new Synchron (R) C-RP reagent in the determination of the atherosclerotic risk in apparently healthy patients..55th Annual Meeting of the American-Association-for-Clinical-Chemiatry (PHILADELPHIA (Pennsylvania), Jul 20-24, 2003). In: Clinical Chemistry (Washington, DC) : international journal of molecular diagnostics and laboratory medicine, Vol. 49, no. 6, p. A113-A114 (2003) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/61484 |